Archives for 

U.S. Supreme Court Decisions

MYLAN, APOTEX, COHERUS, AND ADELLO FILE AMICUS BRIEFS IN SANDOZ V. AMGEN

Amgen v. Sandoz (filgrastim)  •  Patent Dance  •  U.S. Biosimilar Litigation News  •  U.S. Supreme Court Decisions
As we covered in previous posts, the Supreme Court will hear arguments regarding the Federal Circuit’s interpretation of the BPCIA’s notice of commercial marketing requirement and patent dance provisions in April 2017.  Several amicus briefs in support […]

View More

Supreme Court Announces Briefing Schedule in Amgen v. Sandoz

Amgen v. Sandoz (pegfilgrastim)  •  BPCIA and Related U.S. Statutes  •  Patent Dance  •  U.S. Biosimilar Litigation News  •  U.S. Supreme Court Decisions
The Supreme Court has ordered a briefing schedule in Amgen v. Sandoz. Because the Court granted and consolidated Sandoz’s petition and Amgen’s conditional cross-petition, the Court has adopted a four-brief schedule, comparable to […]

View More